1 |
International Commission on Radiation Units and Measurements. Report 38. Dose and volume specification for reporting intracavitary therapy in gynecology. Washington, DC: International Commission on Radiation Units and Measurements; Bethesda. 1985
|
2 |
Inoue T. Harada K. Hata K. et al. A modified dose monitoring system in remote afterloading therapy of carcinoma of the uterine cervix using semi-conductor dosimeter. Strahlentherapie 1981;157:400-404
|
3 |
Choi P, Teo P. Foo W, et al. High-dose-rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong: unexpectedly high complication rate. Clin Oncol 1992;4:186-191
DOI
|
4 |
Cunningham DE. Stryker JA. Velkley DE. et al. Routine clinical estimation of rectal, rectosigmoidal, and bladder doses from intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1981;7:653-660
DOI
ScienceOn
|
5 |
Sakata K, Nasakura H. Oouchi A, et al. High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications. Int J Radiat Oncol Biol Phys 2002;54:1369-1376
DOI
ScienceOn
|
6 |
Clark BG. Souhami L. Roman TN. et al. The prediction of late rectal complications in patients treated with high dose rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997;38:989-993
DOI
ScienceOn
|
7 |
Deshpande DD. Shrivastav SK. Pradhan AS. et al. Dosimetry of intracavitary applications in carcinoma of the cervix: rectal dose analysis. Radiother Oncol 1997;42:163-166
DOI
ScienceOn
|
8 |
Van Lancker M, Storme G. Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications. Int J Radiat Oncol Biol Phys 1991;20:1125-1129
DOI
ScienceOn
|
9 |
Shigematsu Y. Nishiyama K. Masaki N. et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys 1983;9:351-356
DOI
ScienceOn
|
10 |
Lee SW. Suh CO, Chung EJ, Kim GE. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 2002;52:1338-1344
DOI
ScienceOn
|
11 |
Pourquier H. Dubois JB. Delard R. Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys 1982;8:1887-1895
DOI
ScienceOn
|
12 |
Teshima T. Chatani M. Hata K. et al. High dose rate intracavitary therapy for carcinoma of the uterine cervix: II. Risk factors for rectal complication. Int J Radiat Oncol Biol Phys 1988;14:281-286
DOI
ScienceOn
|
13 |
Petereit DG. Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999;43:359-366
DOI
ScienceOn
|
14 |
Kakinohana Y. Toita T, Ogawa K. et al. Comparison of calculated, and measured rectal doses in HDR brachytherapy with Ir-192 source. Nippon Igaku Hoshasen Gakkai Zasshi 1997;57:265-270
|
15 |
LENT/SOMA scales for all anatomic sites. In J Radiat Oncol Biol Phys 1995;31:1049-1091
DOI
ScienceOn
|
16 |
Ogino I. Kitamura T. Okamoto N. et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys 1995;31: 725-734
DOI
ScienceOn
|
17 |
Lee JE. Huh SJ. Park W. et al. Prediction of late rectal complication following high dose rate intracavitary brachytherapy in cancer of the uterine cervix. J Korean Soc Thera Radio Oncol 2003;21:276-282
|
18 |
Hyun KT, Choi J. Park SY. et al. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. Cancer 2005;104:1304-1311
DOI
ScienceOn
|
19 |
Huh SJ. Lim DH. Ahn YC. et al. Comparison between in vivo dosimetry and barium contrast tachnique for prediction of rectal complications in high dose rate intracavitary radiotherapy in cervix cancer patients. Strahlenther Onkol 2003;3:191-196
|
20 |
Stuecklschweiger GF, Arian-Schad KS, Poier E. et al. Bladder and rectal dose of gynecologic high-dose-rate implants: comparison of orthogonal radiographic measurements with in vivo and CT -assisted measurements. Radiology 1991;181:889-894
DOI
|
21 |
Clark BG, Souhami L. Roman TN. et al. Rectal complications in patients with carcinoma of the cervix treated with concomitant clsplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis. Int J Radiat Oncol Biol Phys 1994;28:1243-1250
DOI
ScienceOn
|
22 |
Toita T. Kakinohana Y. Ogawa K. et al. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys 2003;56:1344-1353
DOI
ScienceOn
|
23 |
Crook JM. Esche BA. Chaplain G. et al. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 1987;8:321-332
DOI
ScienceOn
|
24 |
Rubin P, Constine LS, Williams JP. Late effects of cancer treatment: Radiation and drug toxicity. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 3rd ed. Philadelphia, PA: Lippincott-Raven Co. 1998:155-212
|
25 |
Cheng JC. Peng LC. Chen YH. Huang DY. Wu JK, Jian JJ. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 2003;57:1010-1018
DOI
ScienceOn
|
26 |
Hareyama M. Sakata K. Oouchi A. et al. High dose rate versus low dose rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial. Cancer 2002;94:117-124
DOI
ScienceOn
|